Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Figer

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Gastrointestinal Cancer Research : GCR|June 16, 2011
Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B CirrhosisGhassan K Abou-Alfa, Dino Amadori, Armando Santoro, et al.
Genetic Testing|January 6, 2001
Genetic analyses of male breast cancer in IsraelR S Sverdlov, I Barshack, R B Bar Sade, et al.
British Journal of Cancer|November 27, 2001
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic casesA Figer, R Shtoyerman-Chen, A Tamir, et al.
Journal of Surgical Oncology|May 18, 2006
Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracilRinat Yerushalmi, Efraim Idelevich, Ygael Dror, et al.
Cancer|October 30, 2007
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 studyArié Figer, Nathalie Perez-Staub, Elisabeth Carola, et al.
Breast Cancer Research and Treatment|June 16, 1999
Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patientsI Cohen, E Perel, R Tepper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 studyF-C Bidard, C Tournigand, T André, et al.
The Israel Medical Association Journal : IMAJ|January 15, 2004
Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancerArie Figer, Tal Friedman, Ayse Esra Manguoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancerJim Cassidy, Stephen Clarke, Eduardo Díaz-Rubio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2023
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyLeonard B Saltz, Stephen Clarke, Eduardo Díaz-Rubio, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Gastrointestinal Cancer Research : GCR|June 16, 2011
Safety and Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma (HCC) and Child-Pugh A versus B CirrhosisGhassan K Abou-Alfa, Dino Amadori, Armando Santoro, et al.
Genetic Testing|January 6, 2001
Genetic analyses of male breast cancer in IsraelR S Sverdlov, I Barshack, R B Bar Sade, et al.
British Journal of Cancer|November 27, 2001
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic casesA Figer, R Shtoyerman-Chen, A Tamir, et al.
Journal of Surgical Oncology|May 18, 2006
Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracilRinat Yerushalmi, Efraim Idelevich, Ygael Dror, et al.
Cancer|October 30, 2007
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 studyArié Figer, Nathalie Perez-Staub, Elisabeth Carola, et al.
Breast Cancer Research and Treatment|June 16, 1999
Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patientsI Cohen, E Perel, R Tepper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 studyF-C Bidard, C Tournigand, T André, et al.
The Israel Medical Association Journal : IMAJ|January 15, 2004
Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancerArie Figer, Tal Friedman, Ayse Esra Manguoglu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancerJim Cassidy, Stephen Clarke, Eduardo Díaz-Rubio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2023
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III StudyLeonard B Saltz, Stephen Clarke, Eduardo Díaz-Rubio, et al.
Pageof 11